Overview
Obligated since award on contracts active FY2021–FY2026
Click a company to open its profile.
Insight 260-NETWORK CONTRACT OFFICE 20 (36C260) is its largest buyer. See more on the Buyers tab
Agencies report with a delay; the latest year will rise
Hover over a year to see its value.
Insight Largest year: $320K in FY2020; since FY2021, $159K in FY2024. See more on the Contracts tab
$671K since award = $473K in FY2021–FY2026 + $197K before FY2021
Click a state to open its page.
- Tennessee$346K · 52%
- District of Columbia$293K · 44%
- Pennsylvania$31.2K · 4.7%
Insight 52% was performed in Tennessee. See more on the Contracts tab
Contracts
11 contracts with an action since FY2021
Click a tile to open its contract.
Insight V797D70102 orders hold 88% of these contracts' obligations.
In FY2023, its other prime contracts net below zero after deobligations, so V797D70102 orders exceed all prime contracts
Hover over a year to see its value.
Insight 68% of its prime obligations came through V797D70102 orders.
Current end date of each prime contract with an action since FY2021
Hover over a month to see its value.
Vanda Pharmaceuticals Inc. prime contracts with an action in FY2021–FY2026
Find a contract by vehicle, office or end date; sort by money to see the largest.
0 end within 12 months.
Showing 1–10 of 11 contracts
| Since award, US$ | |||||
|---|---|---|---|---|---|
| Parent contract (IDVIDV: the record type for any contract that exists to take orders: IDIQs, GWACs, GSA Schedules, BPAs and basic ordering agreements. Glossary) | ObligatedObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary | ||||
| 36C26024F0173 | V797D70102 | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $154,049 | Dec 31, 2024 | Ended |
| 36C26025F0002 | V797D70102 | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $131,068 | Sep 30, 2025 | Ended |
| 36C25620F0270 | V797D70102 | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $128,543 | May 12, 2021 | Ended |
| 36C26023F0431 | V797D70102 | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $77,799 | Dec 31, 2023 | Ended |
| 36C25222F0066 | V797D70102 | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $34,999 | Dec 14, 2021 | Ended |
| 36C25222F0228 | V797D70102 | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $32,891 | Jun 30, 2022 | Ended |
| 36C25222N0306 | VA797E17A0008 | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $32,891 | Apr 11, 2022 | Ended |
| 36C25221F0086 | V797D70102 | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $31,181 | Dec 31, 2020 | Ended |
| 36C26026F0025 | 36F79724D0191 | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $26,344 | Sep 30, 2026 | Ended |
| 36C26220F0356 | VA797E17A0008 | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $20,788 | Sep 30, 2020 | Ended |
Buyers
Department of Veterans Affairs: $671K obligated since award; $478K in FY2021–FY2025 actions
Click a tile to open its office page.
Insight Department of Veterans Affairs placed 100%.
Contracting offices that awarded Vanda Pharmaceuticals Inc. prime contracts, FY2021–FY2026
See which offices award its contracts.
1 office awarded only one contract.
Showing 1–4 of 4 offices
| Contracts active FY2021–FY2026; obligated since award, US$ | |||||
|---|---|---|---|---|---|
| 260-NETWORK CONTRACT OFFICE 20 (36C260) | Department of Veterans Affairs | 4 | $389,259 | Aug 14, 2023 | May 1, 2026 |
| 252-NETWORK CONTRACT OFFICE 12 (36C252) | Department of Veterans Affairs | 4 | $131,962 | Dec 14, 2020 | Jun 9, 2022 |
| 256-NETWORK CONTRACT OFFICE 16 (36C256) | Department of Veterans Affairs | 1 | $128,543 | May 13, 2020 | Jun 14, 2021 |
| 262-NETWORK CONTRACT OFFICE 22 (36C262) | Department of Veterans Affairs | 2 | $20,788 | Apr 1, 2020 | Dec 9, 2022 |
Opportunities
Open opportunities matching Vanda Pharmaceuticals Inc.'s registered industries
Notices in its 1 industry (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary): 325412
8 of the next 10 are due within 30 days.
Showing 1–10 of 10 opportunities
| Opportunity | Agency | Due |
|---|---|---|
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America (opens in Procura)Presolicitation · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNAC PHARMACEUTICALS (36E797) | Oct 21, 2026 |
| Inhaled Nitric Oxide (opens in Procura)Sources Sought · NAICS 325412Free account: full notice, dates, attachments | Defense Health Agency (DOD)DEFENSE HEALTH AGENCY (HT9408) | Oct 22, 2026 |
| Methylphenidate ER (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Defense Logistics Agency (DOD)DLA TROOP SUPPORT (SPE2D2) | Oct 23, 2026 |
| Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Defense Health Agency (DOD)DEFENSE HEALTH AGENCY (DHA) (HT0040) | Oct 26, 2026 |
| 6505--Imatinib Tablets (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNAC PHARMACEUTICALS (36E797) | Oct 30, 2026 |
| 6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 (opens in Procura)Sources Sought · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans Affairs250-NETWORK CONTRACT OFFICE 10 (36C250) | Nov 3, 2026 |
| LIDOCAINE 5% PATCHES-REQUEST FOR INFORMATION (opens in Procura)Sources Sought · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNATIONAL CMOP OFFICE (36C770) | Nov 3, 2026 |
| Epinephrine Injector (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Defense Logistics Agency (DOD)DLA TROOP SUPPORT (SPE2D2) | Nov 16, 2026 |
| 6505--Department of Veterans Affairs Pharmaceutical Industry Day (opens in Procura)Special Notice · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNAC FEDERAL SUPPLY SCHEDULE (36F797) | Nov 20, 2026 |
| TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform (opens in Procura)Special Notice · NAICS 325412Free account: full notice, dates, attachments | Department of EnergyOffice 899015 | Dec 4, 2026 |
Registration and contacts
Registration
- UEI
- NG5JU1TQ3379
- CAGE code
- 68U09
- Registration
- Active, expires Jul 26, 2027
- Entity type
- Corporate Entity (Not Tax Exempt)
- Location
- WASHINGTON, DC, 20037
- Congressional district
- DC-98
Registered industries (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary)
Registered in 1 industry; primary 325412
- 325412 Pharmaceutical Preparation ManufacturingPrimary
Contacts at Vanda Pharmaceuticals Inc.
| Contact | Role | As of |
|---|---|---|
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Government business POC · Electronic business POC · Company contactSAM.gov registrationSBA profileAs of Oct 4, 2026 | Oct 4, 2026 |
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Alternate electronic business POCSAM.gov registrationAs of Aug 10, 2026 | Aug 10, 2026 |
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Past performance POCSAM.gov registrationAs of Aug 10, 2026 | Aug 10, 2026 |
Correct this listing
Tell us what to correct or add on the Vanda Pharmaceuticals Inc. page. We check every request before we change a profile.